Acorah Software Products - Accounts Production 16.8.200 false true 31 March 2024 1 April 2023 false true No description of principal activity 1 April 2024 31 March 2025 31 March 2025 09061417 Mr Sachin Patel iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 09061417 2024-03-31 09061417 2025-03-31 09061417 2024-04-01 2025-03-31 09061417 frs-core:CurrentFinancialInstruments 2025-03-31 09061417 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09061417 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 09061417 frs-bus:Micro-entities 2024-04-01 2025-03-31 09061417 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 09061417 frs-bus:Director1 2024-04-01 2025-03-31 09061417 2023-03-31 09061417 2024-03-31 09061417 2023-04-01 2024-03-31 09061417 frs-core:CurrentFinancialInstruments 2024-03-31
Registered number: 09061417
Pharmaforce Ltd
Unaudited Financial Statements
For The Year Ended 31 March 2025
Balance Sheet
Registered number: 09061417
2025 2024
£ £
Current assets 36,892 103,544
Creditors: Amounts Falling Due Within One Year (5,756 ) (55,700 )
NET CURRENT ASSETS 31,136 47,844
TOTAL ASSETS LESS CURRENT LIABILITIES 31,136 47,844
NET ASSETS 31,136 47,844
CAPITAL AND RESERVES 31,136 47,844

Notes

1. General Information
Pharmaforce Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 09061417 . The registered office is 47 Victoria Avenue, Wembley, Middlesex, HA9 6QD.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Sachin Patel
Director
12/12/2025